Medicine Details
Brand name – Velasof
Generic name – Sofosbuvir/Velpatasvir
Manufacturer – Hetero Health Care
Salt composition – Sofosbuvir and Velpatasvir
Storage – Store at room temperature (10-30°C)
Dosage form – Oral (tablet)
Strength – 400mg + 100mg
Packaging – Bottle of 28 tablets
Gender – Unisex
Active ingredient – Sofosbuvir/Velpatasvir
Prescription required – Yes
Indication – Used in the treatment of chronic hepatitis C virus infection
Description
Velasof is a combination of two antivirals. It is used in the treatment of chronic hepatitis C virus infection. Velasof (Sofosbuvir and Velpatasvir) stops the multiplication of the virus in the body. Velasof can be taken with or without food. Try to take it at the same time every day. Velasof is not recommended to patients having a known history of Hepatitis B virus infection due to the high risk of adverse reaction.
Pharmacodynamics
The effect of Sofosbuvir (Velasof) 400 mg (recommended dosage) and 1200 mg (three times the recommended dosage) on QTc interval was demonstrated in an active-controlled (moxifloxacin 400 mg) thorough QT trial. Sofosbuvir (Velasof) does not prolong QTc to any clinically relevant extent, at three times the recommended dose. The effect of Velpatasvir (Velasof) 500 mg (five times the recommended dosage) was demonstrated in an active-controlled (moxifloxacin 400 mg) thorough QT trial. Velpatasvir (Velasof) does not prolong QTc interval to any clinically relevant extent, at five times the recommended dose.
Ingredients
The active ingredient of Velasof is Sofosbuvir (400mg)/Velpatasvir (100mg).
Usage Of Medicine
Velasof is used in the treatment of chronic hepatitis C virus infection. Hepatitis C is a liver infection caused by Hepatitis C Virus (HPV). Therefore, Velasof helps to control the infection.
Alternate Brands
- Velpanat tablet
- Resof total tablet
- Sofocure-v tablet
- Sovihep-v tablet
- Valpaclear tablet